Stocks / Pharmaceuticals

VKTXPharmaceuticals

Viking Therapeutics, Inc
$29.411d -1.1%5d -8.7%settled close · 2026-09-17
Mkt cap $3.7B (3/25)β 0.8752w $28–42Shares 115.6MInd. Pharmaceutical PreparationsNasdaq since 2015Emp. 53HQ San Diego, CAvikingtherapeutics.com
Who’s talkingIdea Scout · free

Who’s talking about VKTX

No tracked investor commentary on VKTX yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 20 Oct 2026 after the close

Confirmed date · consensus EPS -1.09. Reactions below are the next settled session over the prior close.
The options tape

Notable options days

Sessions in the last 120 where VKTX’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 10 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-09
2026-09-08
2026-08-24
2026-08-19
2026-06-30
2026-06-25
2026-06-24
2026-06-23
2026-06-22
2026-05-18
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on VKTX is in this morning’s Brief. Get The Brief — $20/mo →